Skip to main content
Board of Directors
Innovation engine overview
Extracting microbial biodiversity
Screening for new activity
Active compound characterization
Technology platform overview
DEINOVE is pioneering the exploration of “microbial dark matter”
By revealing the metabolic potential of rare bacteria or still classified as uncultivable, the company tackles a global health and economic challenge:
DEINOVE- Adoption of all the ordinary resolutions at the Shareholders’ Meeting of June 21, 2021
The Extraordinary Shareholders’ Meeting will be convened on third notice at a later date DEINOVE (...
DEINOVE- Second convening to a Combined General Meeting on June 21, 2021
DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company, pioneer in the exploration and...
More press releases